Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

In the original version of this article (1), the prevalence rates of COVID-19 in patients with COPD baseline were incorrectly stated in both the “No prior PD-1 blockade (n = 28)” and “Prior PD-1 blockade (n = 41)” columns in Table 2. We have corrected these errors by replacing “9%” with “11%” in the column titled “No prior PD-1 blockade (n = 28)” and “36%” with “22%” in the column titled “Prior PD-1 blockade (n = 41)” in latest online HTML and PDF versions of the article. The authors regret the error.